French Polynesia
High income
- Ülevaade
- Rasvumise levimus
- Rahvastiku jaotus
- Tegurid
- Kaasnevad haigused
- Strateegiad
Info laeb. Palun oodake!
Report cards
Our report cards collate all the most-recent graphics for this country. If you would like to produce a custom report based on selected graphics, just tap the Add to custom PDF button below the graphics you would like to use.
Rahvastiku jaotus
Tegurid
Kaasnevad haigused
Rasvumise levimus
Täiskasvanud, 2010
Uuringu tüüp: | Mõõdetud |
Vanus: | 18-64 |
Valimi suurus: | 3368 |
Hõlmatud piirkond: | Riiklik |
Viited: | French Polynesia STEPS Survey 2010 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Täiskasvanud, 2007-2008
Uuringu tüüp: | Mõõdetud |
Vanus: | 15+ |
Valimi suurus: | 605 |
Hõlmatud piirkond: | Riiklik |
Viited: | Daigre J-L, et al. The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: The PODIUM survey. Diabetes Metab (2012), http://dx.doi.org/10.1016/j.diabet.2012.03.008 |
Märkused: | Small sample size |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Lapsed, 2024
Uuringu tüüp: | Ise teatatud |
Vanus: | 13-17 |
Valimi suurus: | 3118 |
Hõlmatud piirkond: | Riiklik |
Viited: | 2024 GSHS Fact Sheet French Polynesia. Available at: https://www.who.int/publications/m/item/2024-gshs-fact-sheet-french-polynesia (Accessed: 12.06.25) |
Cutoffs: | WHO 2007 |
Lapsed, 2015
Uuringu tüüp: | Ise teatatud |
Vanus: | 13-17 |
Valimi suurus: | 3216 |
Hõlmatud piirkond: | Riiklik |
Viited: | Global School-based Student Health Survey (GSHS), available at https://www.who.int/ncds/surveillance/gshs/gshs_fs_french_polynesia_2015.pdf?ua=1 (last accessed 14.12.20) |
Cutoffs: | WHO |
Ülekaalulisus / rasvumine vanuse järgi
Täiskasvanud, 2010
Uuringu tüüp: | Mõõdetud |
Hõlmatud piirkond: | Riiklik |
Viited: | French Polynesia STEPS Survey 2010. https://extranet.who.int/ncdsmicrodata/index.php/catalog/662/download/4775 (Accessed 04.01.23) |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Lapsed, 2015
Uuringu tüüp: | Mõõdetud |
Valimi suurus: | 3216 |
Hõlmatud piirkond: | Riiklik |
Viited: | Global School-based Student Health Survey. French Polynesia 2015 Fact Sheet. https://extranet.who.int/ncdsmicrodata/index.php/catalog/657/download/4725 (Accessed 04.01.2023) |
Cutoffs: | WHO |
Double burden of underweight & overweight
Täiskasvanud, 2022
Uuringu tüüp: | Mõõdetud |
Vanus: | 20+ |
Viited: | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2. |
Märkused: | Age Standardised estimates |
Mõisted: | Combined prevalence of BMI<18.5 kg/m² and BMI>=30 kg/m² (double burden of underweight and obesity) |
Lapsed, 2022
Uuringu tüüp: | Mõõdetud |
Vanus: | 5-19 |
Viited: | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2. |
Märkused: | Age standardised estimates |
Mõisted: | Combined prevalence of BMI < -2SD and BMI > 2SD (double burden of thinness and obesity) |
Cutoffs: | BMI < -2SD and BMI > 2SD |
Ebapiisav füüsiline aktiivsus
Täiskasvanud, 2016
Viited: | Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7 |
Mehed, 2016
Viited: | Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7 |
Naised, 2016
Viited: | Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7 |
Söögitoruvähk
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Indicence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Indicence per 100,000 |
Mehed, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Rinnavähk
Naised, 2022
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Pärasoolevähk
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Mehed, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Kõhunäärmevähk
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Mehed, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Sapipõie vähk
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Indicence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Indicence per 100,000 |
Mehed, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Neeruvähk
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Mehed, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Emakavähk
Naised, 2022
Vanus: | 20+ |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Naised, 2020-2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149 |
Mõisted: | Age-standardized indicence rates per 100 000 |
Diabeedi levimus
Täiskasvanud, 2024
Viited: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org |
Täiskasvanud, 2021
Vanus: | 20-79 |
Hõlmatud piirkond: | Riiklik |
Viited: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org |
Mõisted: | Age-adjusted comparative prevalence of diabetes, % |
Täiskasvanud, 2019
Vanus: | 20-79 |
Viited: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org |
Mõisted: | Diabetes age-adjusted comparative prevalence (%). |
Täiskasvanud, 2017
Viited: | Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org |
Mõisted: | Diabetes age-adjusted comparative prevalence (%). |
Ovarian Cancer
Naised, 2022
Vanus: | 20+ |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Leukemia
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Leukemia
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Liver and intrahepatic bile duct Cancer
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Multiple Myeloma
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Indicence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Indicence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Non Hodgkin Lymphoma
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². |
Thyroid Cancer
Mehed, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |
Naised, 2022
Vanus: | 20+ |
Hõlmatud piirkond: | Riiklik |
Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
Mõisted: | Incidence per 100,000 |